Literature DB >> 27388676

3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product.

Anita R Iskandar1, Carole Mathis1, Florian Martin1, Patrice Leroy1, Alain Sewer1, Shoaib Majeed1, Diana Kuehn1, Keyur Trivedi1, Davide Grandolfo1, Maciej Cabanski1, Emmanuel Guedj1, Celine Merg1, Stefan Frentzel1, Nikolai V Ivanov1, Manuel C Peitsch1, Julia Hoeng1.   

Abstract

In vitro toxicology approaches have evolved from a focus on molecular changes within a cell to understanding of toxicity-related mechanisms in systems that can mimic the in vivo environment. The recent development of three dimensional (3-D) organotypic nasal epithelial culture models offers a physiologically robust system for studying the effects of exposure through inhalation. Exposure to cigarette smoke (CS) is associated with nasal inflammation; thus, the nasal epithelium is relevant for evaluating the pathophysiological impact of CS exposure. The present study investigated further the application of in vitro human 3-D nasal epithelial culture models for toxicological assessment of inhalation exposure. Aligned with 3Rs strategy, this study aimed to explore the relevance of a human 3-D nasal culture model to assess the toxicological impact of aerosols generated from a candidate modified risk tobacco product (cMRTP), the Tobacco Heating System (THS) 2.2, as compared with smoke generated from reference cigarette 3R4F. A series of experimental repetitions, where multiple concentrations of THS2.2 aerosol and 3R4F smoke were applied, were conducted to obtain reproducible measurements to understand the cellular/molecular changes that occur following exposure. In agreement with "Toxicity Testing in the 21st Century - a Vision and a Strategy", this study implemented a systems toxicology approach and found that for all tested concentrations the impact of 3R4F smoke was substantially greater than that of THS2.2 aerosol in terms of cytotoxicity levels, alterations in tissue morphology, secretion of pro-inflammatory mediators, impaired ciliary function, and increased perturbed transcriptomes and miRNA expression profiles.

Entities:  

Keywords:  air-liquid interface; cigarette smoke; modified risk tobacco product; organotypic culture; systems toxicology

Mesh:

Substances:

Year:  2016        PMID: 27388676     DOI: 10.14573/altex.1605041

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  7 in total

1.  In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke.

Authors:  Linsey E Haswell; Sarah Corke; Ivan Verrastro; Andrew Baxter; Anisha Banerjee; Jason Adamson; Tomasz Jaunky; Christopher Proctor; Marianna Gaça; Emmanuel Minet
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

2.  Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure.

Authors:  Stéphanie Boué; Thomas Exner; Samik Ghosh; Vincenzo Belcastro; Joh Dokler; David Page; Akash Boda; Filipe Bonjour; Barry Hardy; Patrick Vanscheeuwijck; Julia Hoeng; Manuel Peitsch
Journal:  F1000Res       Date:  2017-01-05

3.  Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics.

Authors:  Linsey E Haswell; Andrew Baxter; Anisha Banerjee; Ivan Verrastro; Jessica Mushonganono; Jason Adamson; David Thorne; Marianna Gaça; Emmanuel Minet
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

4.  Systems toxicology meta-analysis of in vitro assessment studies: biological impact of a candidate modified-risk tobacco product aerosol compared with cigarette smoke on human organotypic cultures of the aerodigestive tract.

Authors:  A R Iskandar; B Titz; A Sewer; P Leroy; T Schneider; F Zanetti; C Mathis; A Elamin; S Frentzel; W K Schlage; F Martin; N V Ivanov; M C Peitsch; J Hoeng
Journal:  Toxicol Res (Camb)       Date:  2017-05-29       Impact factor: 3.524

5.  Comparative effects of a candidate modified-risk tobacco product Aerosol and cigarette smoke on human organotypic small airway cultures: a systems toxicology approach.

Authors:  Anita R Iskandar; Yannick Martinez; Florian Martin; Walter K Schlage; Patrice Leroy; Alain Sewer; Laura Ortega Torres; Shoaib Majeed; Celine Merg; Keyur Trivedi; Emmanuel Guedj; Stefan Frentzel; Carole Mathis; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Toxicol Res (Camb)       Date:  2017-09-28       Impact factor: 3.524

6.  Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia.

Authors:  David Bovard; Marco van der Toorn; Walter K Schlage; Samuel Constant; Kasper Renggli; Manuel C Peitsch; Julia Hoeng
Journal:  Biochem Biophys Rep       Date:  2021-12-15

Review 7.  Air-Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations.

Authors:  Ghislaine Lacroix; Wolfgang Koch; Detlef Ritter; Arno C Gutleb; Søren Thor Larsen; Thomas Loret; Filippo Zanetti; Samuel Constant; Savvina Chortarea; Barbara Rothen-Rutishauser; Pieter S Hiemstra; Emeric Frejafon; Philippe Hubert; Laura Gribaldo; Peter Kearns; Jean-Marc Aublant; Silvia Diabaté; Carsten Weiss; Antoinette de Groot; Ingeborg Kooter
Journal:  Appl In Vitro Toxicol       Date:  2018-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.